Breaking News Instant updates and real-time market news.

2022-07-06 06:03:01 CME CME Group $204.34 / +0.05 (+0.02%) 06:03 07/06/22 07/06 06:03 07/06/22 06:03	CME Group price target lowered to $246 from $258 at UBS UBS analyst Alex Kramm lowered the firm's price target on CME Group to $246 from $258 and keeps a Buy rating on the shares. While volumes for Q2 came in slightly below expectations, Kramm expects recent Fed rate hikes to drive upside to net interest income despite a slight decline in estimated margin deposits, the analyst tells investors in a research note.	27 Jul

2022-07-06 06:03:01

CME

CME Group

$204.34 / +0.05 (+0.02%)

06:03

07/06/22

07/06

06:03

07/06/22

06:03

CME Group price target lowered to $246 from $258 at UBS

UBS analyst Alex Kramm lowered the firm's price target on CME Group to $246 from $258 and keeps a Buy rating on the shares. While volumes for Q2 came in slightly below expectations, Kramm expects recent Fed rate hikes to drive upside to net interest income despite a slight decline in estimated margin deposits, the analyst tells investors in a research note.

27
Jul

OTHER BREAKING NEWS FROM THE FLY

Recommendations	Stantec price target raised to C$74 from C$72 at Scotiabank » 12:11 08/12/22 08/12 12:11 08/12/22 12:11 STN Stantec $49.96 / +1.22 (+2.50%) Scotiabank analyst Mark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research STN Stantec $49.96 / +1.22 (+2.50%) 07/06/22 Stantec selected as Program Managment Consultant for IIWWTP projects 06/28/22 Stantec selected to lead design services of Boston sewer separation project 06/23/22 Stantec awarded engineering during construction of water treatment plant 03/09/22 Stantec to acquire Barton Willmore, terms not disclosed STN Stantec $49.96 / +1.22 (+2.50%) 07/19/22 Stifel IBI Group downgraded to Hold from Buy at Stifel 05/16/22 Desjardins Stantec price target lowered to C$75 from C$81 at Desjardins 05/13/22 BMO Capital Stantec price target lowered to C$72 from C$78 at BMO Capital 05/13/22 Raymond James Stantec price target lowered to C$77 from C$85 at Raymond James
Recommendations	Savaria price target raised to C$17.50 from C$16.50 at Scotiabank » 12:11 08/12/22 08/12 12:11 08/12/22 12:11 SISXF Savaria $11.34 / + (+0.00%) Scotiabank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SISXF Savaria $11.34 / + (+0.00%) 11:59 Today TD Securities Savaria price target raised to C$20 from C$19 at TD Securities 07/19/22 Scotiabank Savaria price target lowered to C$16.50 from C$20 at Scotiabank 05/16/22 Desjardins Savaria price target lowered to C$25 from C$25.50 at Desjardins 05/13/22 Scotiabank Savaria price target lowered to C$20 from C$21 at Scotiabank
Recommendations	Rogers Sugar price target raised to C$6.50 from C$6 at Scotiabank » 12:10 08/12/22 08/12 12:10 08/12/22 12:10 RSGUF Rogers Sugar $5.03 / +0.065 (+1.31%) Scotiabank analyst George… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings RSGUF Rogers Sugar $5.03 / +0.065 (+1.31%) 08/11/22 Rogers Sugar expects improved financial performance in 2022 RSGUF Rogers Sugar $5.03 / +0.065 (+1.31%) 05/04/22 National Bank Rogers Sugar price target raised to C$5.75 from C$5.25 at National Bank 02/11/22 BMO Capital Rogers Sugar price target raised to C$6.50 from C$6 at BMO Capital 11/30/21 Desjardins Rogers Sugar price target raised to C$6 from C$5.75 at Desjardins 11/26/21 BMO Capital Rogers Sugar price target raised to C$6 from C$5.75 at BMO Capital RSGUF Rogers Sugar $5.03 / +0.065 (+1.31%) 08/11/22 Rogers Sugar reports Q3 adjusted EPS C$0.08 vs. C$0.04 last year 05/12/22 Rogers Sugar reports Q2 adjusted EPS C$0.09 vs. C$0.07 last year
Recommendations	Onex price target lowered to C$105 from C$118 at Scotiabank » 12:10 08/12/22 08/12 12:10 08/12/22 12:10 ONEXF Onex $54.83 / +0.04 (+0.07%) Scotiabank analyst Phil… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings ONEXF Onex $54.83 / +0.04 (+0.07%) 07/05/22 ONCAP makes investment in Ideal Dental 06/08/22 Gluskin Sheff launches Onex Partners Private Equity Solution 2022 05/26/22 Ryan to receive investments from Onex, Ares Management 04/13/22 Onex files normal course issuer bid ONEXF Onex $54.83 / +0.04 (+0.07%) 07/28/22 Canaccord Onex price target lowered to C$91 from C$104 at Canaccord 05/16/22 Canaccord Onex price target lowered to C$104 from C$110 at Canaccord 05/16/22 RBC Capital Onex price target raised to C$110 from C$108 at RBC Capital 05/16/22 TD Securities Onex price target raised to C$115 from C$110 at TD Securities ONEXF Onex $54.83 / +0.04 (+0.07%) 08/11/22 Onex reports Q2 EPS ($2.15) vs. $1.95 last year 02/25/22 Onex reports Q4 segment EPS $3.65 vs. $7.72 last year
Recommendations	Kits Eyecare price target lowered to C$3.50 from C$5 at Scotiabank » 12:09 08/12/22 08/12 12:09 08/12/22 12:09 KTYCF Kits Eyecare $2.32 / +0.49 (+26.78%) Scotiabank analyst George… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research KTYCF Kits Eyecare $2.32 / +0.49 (+26.78%) 05/12/22 Canaccord Kits Eyecare price target lowered to C$7 from C$8 at Canaccord 11/17/21 Canaccord Kits Eyecare price target lowered to C$8 from C$11 at Canaccord 11/17/21 Scotiabank Kits Eyecare price target lowered to C$5 from C$7.50 at Scotiabank 08/13/21 Scotiabank Kits Eyecare price target lowered to C$7.50 from C$10.50 at Scotiabank
Recommendations	KP Tissue price target lowered to C$11 from C$11.50 at Scotiabank » 12:09 08/12/22 08/12 12:09 08/12/22 12:09 KPTSF KP Tissue $7.90 / + (+0.00%) Scotiabank analyst Benoit… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings KPTSF KP Tissue $7.90 / + (+0.00%) 08/11/22 KP Tissue anticipates momentum in Q3 revenue for Consumer, AFH 03/10/22 KP Tissue sees Q1 adjusted EBITDA C$30M-C$35M KPTSF KP Tissue $7.90 / + (+0.00%) 11:55 Today TD Securities KP Tissue price target lowered to C$10.50 from C$11.50 at TD Securities 05/13/22 RBC Capital KP Tissue price target lowered to C$10 from C$11 at RBC Capital 03/11/22 RBC Capital KP Tissue downgraded to Sector Perform from Outperform at RBC Capital 11/16/21 Desjardins KP Tissue price target lowered to C$11 from C$11.50 at Desjardins KPTSF KP Tissue $7.90 / + (+0.00%) 08/11/22 KP Tissue reports Q2 EPS (C$0.40) vs. (C$0.13) last year 05/12/22 KP Tissue reports Q1 EPS C$0.10c vs C$0.12c last year 03/10/22 KP Tissue reports Q4 EPS C$0.35 vs. (C$0.44) last year
Recommendations	Dialogue Health price target lowered to C$8 from C$8.50 at Scotiabank » 12:08 08/12/22 08/12 12:08 08/12/22 12:08 DLHTF Dialogue Health $2.30 / + (+0.00%) Scotiabank analyst Adam… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research DLHTF Dialogue Health $2.30 / + (+0.00%) 11:55 Today TD Securities Dialogue Health price target lowered to C$4.50 from C$5.50 at TD Securities 08/09/22 National Bank Dialogue Health price target lowered to C$8.50 from C$11.50 at National Bank
Recommendations	Chemtrade Logistics price target raised to C$10.50 from C$10.25 at Scotiabank » 12:07 08/12/22 08/12 12:07 08/12/22 12:07 CGIFF Chemtrade Logistics $7.11 / +0.5 (+7.56%) Scotiabank analyst Ben… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research CGIFF Chemtrade Logistics $7.11 / +0.5 (+7.56%) 06/27/22 Scotiabank Chemtrade Logistics upgraded to Outperform from Sector Perform at Scotiabank 05/12/22 Scotiabank Chemtrade Logistics price target raised to C$9.50 from C$8.50 at Scotiabank 05/11/22 BMO Capital Chemtrade Logistics price target raised to C$8 from C$7.50 at BMO Capital 05/11/22 National Bank Chemtrade Logistics price target raised to C$9.25 from C$8.75 at National Bank
Recommendations	Badger Infrastructure price target lowered to C$38 from C$40 at Scotiabank » 12:05 08/12/22 08/12 12:05 08/12/22 12:05 BADFF Badger Infrastructure $25.24 / +0.74 (+3.02%) Scotiabank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research BADFF Badger Infrastructure $25.24 / +0.74 (+3.02%) 11:53 Today TD Securities Badger Infrastructure price target raised to C$34 from C$33 at TD Securities 05/16/22 CIBC Badger Infrastructure price target raised to C$31.50 from C$30 at CIBC 05/16/22 Stifel Badger Infrastructure price target raised to C$35 from C$34.50 at Stifel 05/16/22 Scotiabank Badger Infrastructure price target raised to C$40 from C$39 at Scotiabank
Recommendations	Antofagasta price target lowered to 1,250 GBp from 1,300 GBp at Scotiabank » 12:05 08/12/22 08/12 12:05 08/12/22 12:05 ANFGF Antofagasta $13.25 / + (+0.00%) Scotiabank analyst Orest… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research ANFGF Antofagasta $13.25 / + (+0.00%) 07/29/22 RBC Capital Antofagasta upgraded to Sector Perform from Underperform at RBC Capital 07/21/22 JPMorgan Antofagasta price target lowered to 1,460 GBp from 1,480 GBp at JPMorgan 07/21/22 RBC Capital Antofagasta price target lowered to 1,000 GBp from 1,050 GBp at RBC Capital 07/19/22 Morgan Stanley Antofagasta price target lowered to 1,320 GBp from 1,370 GBp at Morgan Stanley

Recommendations	Illumina price target lowered to $240 from $350 at Morgan Stanley » 12:04 08/12/22 08/12 12:04 08/12/22 12:04 ILMN Illumina $207.96 / -19.68 (-8.65%) Morgan Stanley analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options ILMN Illumina $207.96 / -19.68 (-8.65%) 08/11/22 Illumina cuts FY22 core Illumina revenue growth view to 3.5%-4.5% 08/11/22 Illumina drops 22% to $177 after Q2 results miss estimates, FY22 guidance cut 06/09/22 Illumina drops 6% to $210.00 after departure of CFO 06/09/22 Illumina CFO Sam Samad to depart, Joydeep Goswami named interim CFO ILMN Illumina $207.96 / -19.68 (-8.65%) 09:17 Today BofA Illumina price target lowered to $200 from $220 at BofA 08:45 Today Piper Sandler Piper a buyer of Illumina weakness ahead of Genomics Forum 07:44 Today Canaccord Illumina price target lowered to $380 from $450 at Canaccord 07:16 Today Stifel Illumina price target lowered to $300 from $480 at Stifel ILMN Illumina $207.96 / -19.68 (-8.65%) 08/11/22 Illumina cuts FY22 adjusted EPS view to $2.75-$2.90 from $4.00-$4.20 08/11/22 Illumina reports Q2 adjusted EPS 57c, consensus 65c 08/11/22 Notable companies reporting after market close 05/05/22 Illumina sees FY22 adjusted EPS $4.00-$4.20, consensus $4.15 ILMN Illumina $207.96 / -19.68 (-8.65%) 07/27/22 Illumina's Grail deal likely to be blocked by EU regulators, Reuters reports 07/13/22 Illumina lost bid to block EU watchdog review of Grail deal, Bloomberg reports ILMN Illumina $207.96 / -19.68 (-8.65%) 08:59 Today Fly Intel: Pre-market Movers 08/11/22 Fly Intel: After-Hours Movers 07/13/22 What You Missed On Wall Street On Wednesday 07/13/22 What You Missed On Wall Street This Morning 09/10/22 ESMO Congress 2022 ILMN Illumina $207.96 / -19.68 (-8.65%) 08/11/22 Illumina options imply 6.5% move in share price post-earnings 06/13/22 Illumina put buyer realizes 25% same-day gains 05/18/22 Early notable gainers among liquid option names on May 18th
Recommendations	AG Growth International price target raised to C$55 from C$52 at Scotiabank » 12:04 08/12/22 08/12 12:04 08/12/22 12:04 AGGZF AG Growth International $29.81 / +3.80715 (+14.64%) Scotiabank analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research AGGZF AG Growth International $29.81 / +3.80715 (+14.64%) 04/20/22 Scotiabank AG Growth International price target raised to C$52 from C$50 at Scotiabank 03/17/22 RBC Capital AG Growth International price target raised to C$50 from C$45 at RBC Capital 03/11/22 National Bank AG Growth International price target raised to C$49 from C$46 at National Bank 03/11/22 Desjardins AG Growth International price target raised to C$53 from C$49 at Desjardins
Recommendations	Humacyte price target lowered to $3.50 from $4.00 at Piper Sandler » 12:02 08/12/22 08/12 12:02 08/12/22 12:02 HUMA Humacyte $4.44 / +0.06 (+1.37%) Piper Sandler analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events HUMA Humacyte $4.44 / +0.06 (+1.37%) 07/19/22 Humacyte announces presentation of preclinical data on HAV 07/07/22 Humacyte to host KOL webinar on Human Acellular Vessels 06/29/22 Humacyte announces JAMA Surgery publication on HAV's potential 06/21/22 Humacyte provides update on patients treated with HAV in Ukraine HUMA Humacyte $4.44 / +0.06 (+1.37%) 07/18/22 BTIG Humacyte price target lowered to $10 from $12 at BTIG 05/15/22 Piper Sandler Humacyte downgraded to Underweight from Overweight at Piper Sandler 03/29/22 Piper Sandler Humacyte price target lowered to $10 from $17 at Piper Sandler 10/29/21 Cowen Humacyte initiated with an Outperform at Cowen HUMA Humacyte $4.44 / +0.06 (+1.37%) 07:03 Today Humacyte reports Q2 EPS 35c, consensus (22c) 05/13/22 Humacyte reports Q1 EPS (19c), consensus (21c) 03/29/22 Humacyte reports Q4 EPS 41c, consensus (20c) HUMA Humacyte $4.44 / +0.06 (+1.37%) 05/16/22 What You Missed On Wall Street On Monday 05/16/22 What You Missed On Wall Street This Morning 08:00 Today Humacyte - HUMA
Hot Stocks	SmartRent falls -32.7% » 12:00 08/12/22 08/12 12:00 08/12/22 12:00 SMRT SmartRent $3.78 / -1.785 (-32.10%) SmartRent is down -32.7%,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly SMRT SmartRent $3.78 / -1.785 (-32.10%) 10:00 Today SmartRent falls -26.6% 09:47 Today SmartRent falls -19.5% 08/11/22 SmartRent falls 28% to $4.02 after Q2 earnings miss and guidance cut 05/17/22 SmartRent director buys $1.04M in common stock SMRT SmartRent $3.78 / -1.785 (-32.10%) 08:15 Today Cantor Fitzgerald SmartRent price target lowered to $5.25 from $6.00 at Cantor Fitzgerald 07/22/22 Cantor Fitzgerald SmartRent assumed with an Overweight at Cantor Fitzgerald 07/19/22 Keefe Bruyette Bain Capital sold 5% of stake in SmartRent, says Keefe Bruyette 05/25/22 Compass Point Compass Point starts SmartRent at Buy, sees 'exponential growth potential' SMRT SmartRent $3.78 / -1.785 (-32.10%) 08/11/22 SmartRent cuts FY22 revenue view to $155M-$180M from $220M-$250M 08/11/22 SmartRent sees Q3 revenue $43M-$47M, consensus $75.4M 08/11/22 SmartRent reports Q2 EPS (13c), consensus (11c) 05/11/22 SmartRent sees FY22 revenue $220M-$250M, consensus $238.1M SMRT SmartRent $3.78 / -1.785 (-32.10%) 08/11/22 Fly Intel: After-Hours Movers 05/11/22 Fly Intel: After-Hours Movers 03/24/22 Fly Intel: After-Hours Movers 02/15/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Hot Stocks	Olo falls -33.8% » 12:00 08/12/22 08/12 12:00 08/12/22 12:00 OLO Olo $8.60 / -4.42 (-33.95%) Olo is down -33.8%, or… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly OLO Olo $8.60 / -4.42 (-33.95%) 10:00 Today Olo falls -27.6% 09:47 Today Olo falls -32.1% 05/10/22 Olo appoints Diego Panama as chief revenue officer 04/14/22 Olo, SOCi partner for SOCi integration with Olo API OLO Olo $8.60 / -4.42 (-33.95%) 09:24 Today RBC Capital Olo price target lowered to $12 from $17 at RBC Capital 09:07 Today Truist Olo price target lowered to $16 from $25 at Truist 05:47 Today Piper Sandler Olo downgraded to Neutral from Overweight at Piper Sandler 05:26 Today Stifel Olo downgraded to Hold from Buy at Stifel OLO Olo $8.60 / -4.42 (-33.95%) 08/11/22 Olo cuts FY22 revenue view to $183M-$184M, consensus $195.6M 08/11/22 Olo sees Q3 revenue $46.5M-$47.0M, consensus $51.1M 08/11/22 Olo reports Q2 EPS 1c, consensus 0c 05/10/22 Olo sees Q2 revenue $45.5M-$46M, consensus $45.48M OLO Olo $8.60 / -4.42 (-33.95%) 09:34 Today Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08/11/22 Fly Intel: After-Hours Movers
Hot Stocks	CS Disco falls -54.0% » 12:00 08/12/22 08/12 12:00 08/12/22 12:00 LAW CS Disco $13.35 / -15.61 (-53.90%) CS Disco is down -54.0%,… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly LAW CS Disco $13.35 / -15.61 (-53.90%) 10:00 Today CS Disco falls -51.9% 09:47 Today CS Disco falls -48.4% 06/06/22 DISCO appoints Tom Furr as CMO 06/01/22 CS Disco falls -10.8% LAW CS Disco $13.35 / -15.61 (-53.90%) 07:45 Today Canaccord CS Disco downgraded to Hold at Canaccord as estimates get reset 07:15 Today Stifel CS Disco price target lowered to $30 from $40 at Stifel 06:15 Today BofA CS Disco downgraded to Neutral from Buy at BofA 06:05 Today Canaccord CS Disco downgraded to Hold from Buy at Canaccord LAW CS Disco $13.35 / -15.61 (-53.90%) 08/11/22 CS Disco cuts FY22 revenue view to $132M-$136M from $149M-$153M 08/11/22 CS Disco sees Q3 revenue $32M-$34M, consensus $38.29M 08/11/22 CS Disco reports Q2 adjusted (23c), consensus (27c) 05/12/22 CS Disco sees Q2 revenue $32M-$34M, consensus $34.02M 15 Sep LAW CS Disco $13.35 / -15.61 (-53.90%) 09:34 Today Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 08:59 Today Fly Intel: Pre-market Movers 08/11/22 Fly Intel: After-Hours Movers 05/12/22 Fly Intel: After-Hours Movers
Hot Stocks	ESS Inc. rises 17.5% » 12:00 08/12/22 08/12 12:00 08/12/22 12:00 GWH ESS Inc. $4.91 / +0.725 (+17.32%) ESS Inc. is up 17.5%, or… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings GWH ESS Inc. $4.91 / +0.725 (+17.32%) 10:00 Today ESS Inc. rises 14.6% 09:47 Today ESS Inc. rises 10.0% 08/11/22 ESS Inc. announces partnership to deploy long-term energy storage in Australia 03/24/22 ESS Inc. rises 10.9% GWH ESS Inc. $4.91 / +0.725 (+17.32%) 07/13/22 Canaccord ESS Inc. assumed with a Hold at Canaccord 06/29/22 Chardan ESS Inc. initiated with a Neutral at Chardan 03/30/22 Deutsche Bank ESS Inc. initiated with a Hold at Deutsche Bank 03/22/22 Guggenheim Guggenheim starts ESS Inc. at Buy on flow battery odds of success GWH ESS Inc. $4.91 / +0.725 (+17.32%) 08/11/22 ESS Inc. reports Q2 EPS (10c), consensus (15c) 05/12/22 ESS Inc. reports Q1 EPS (4c), consensus (13c) 02/24/22 ESS Inc. reports Q4 EPS ($1.33) vs. (41c) last year
Hot Stocks	Xponential Fitness rises 21.1% » 12:00 08/12/22 08/12 12:00 08/12/22 12:00 XPOF Xponential Fitness $19.65 / +3.42 (+21.07%) Xponential Fitness is up… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate On The Fly XPOF Xponential Fitness $19.65 / +3.42 (+21.07%) 10:00 Today Xponential Fitness rises 22.6% 08/01/22 Xponential Fitness signs master franchise agreement in Japan for CycleBar 07/27/22 Xponential Fitness reports Q2 system-wide sales to $250M up 45% from last year 05/10/22 Xponential Fitness in franchise pact in Mexico for three brands XPOF Xponential Fitness $19.65 / +3.42 (+21.07%) 06/13/22 Jefferies Jefferies names five top picks in lifestyle and growth platforms 03/14/22 Evercore ISI Evercore ISI starts Xponential Fitness at Outperform with $34 price target 03/14/22 Evercore ISI Xponential Fitness initiated with an Outperform at Evercore ISI 03/14/22 Baird Xponential Fitness price target raised to $28 from $26 at Baird XPOF Xponential Fitness $19.65 / +3.42 (+21.07%) 08/11/22 Xponential Fitness raises FY22 revenue view to $211M-$221M from $201M-$211M 08/11/22 Xponential Fitness reports Q2 EPS 50c 05/12/22 Xponential Fitness backs FY22 revenue $201M-$211M, consensus $209.85M 05/12/22 Xponential Fitness reports Q1 adjusted EPS (19c), consensus 12c 07 Apr XPOF Xponential Fitness $19.65 / +3.42 (+21.07%) 04/05/22 What You Missed On Wall Street This Morning 04/05/22 Fly Intel: Pre-market Movers 04/04/22 Fly Intel: After-Hours Movers
Hot Stocks	Invitae rises 29.0% » 12:00 08/12/22 08/12 12:00 08/12/22 12:00 NVTA Invitae $5.81 / +1.28 (+28.29%) Invitae is up 29.0%, or… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options NVTA Invitae $5.81 / +1.28 (+28.29%) 10:00 Today Invitae rises 20.6% 08/11/22 Invitae falls -42.9% 08/11/22 Invitae falls -39.0% 08/11/22 Invitae falls -25.4% NVTA Invitae $5.81 / +1.28 (+28.29%) 08/10/22 JPMorgan Invitae cut to Underweight at JPMorgan with future growth yet to be proven 08/10/22 JPMorgan Invitae downgraded to Underweight from Neutral at JPMorgan 07/26/22 Cowen Invitae cut to Market Perform at Cowen on debt refinancing uncertainty 07/26/22 Cowen Invitae downgraded to Market Perform from Outperform at Cowen NVTA Invitae $5.81 / +1.28 (+28.29%) 08/09/22 Invitae backs FY22 revenue growth of low double digits, consensus $542.96M 08/09/22 Invitae reports Q2 adjusted EPS (68c), consensus (76c) 07/18/22 Invitae sees second half of FY22 revenue flat over first half of FY22 07/18/22 Invitae sees Q2 revenue $136M, consensus $142.74M NVTA Invitae $5.81 / +1.28 (+28.29%) 08/10/22 What You Missed On Wall Street On Wednesday 08/10/22 What You Missed On Wall Street This Morning 07/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 07/18/22 Fly Intel: After-Hours Movers 09/10/22 ESMO Congress 2022 NVTA Invitae $5.81 / +1.28 (+28.29%) 09:40 Today Unusually active option classes on open August 12th 08/11/22 Invitae call buyer realizes 3500% same-day gains 05/03/22 Invitae options imply 14.1% move in share price post-earnings 02/24/22 Invitae options imply 14.1% move in share price post-earnings
Recommendations	Savaria price target raised to C$20 from C$19 at TD Securities » 11:59 08/12/22 08/12 11:59 08/12/22 11:59 SISXF Savaria $11.34 / + (+0.00%) TD Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research SISXF Savaria $11.34 / + (+0.00%) 07/19/22 Scotiabank Savaria price target lowered to C$16.50 from C$20 at Scotiabank 05/16/22 Desjardins Savaria price target lowered to C$25 from C$25.50 at Desjardins 05/13/22 Scotiabank Savaria price target lowered to C$20 from C$21 at Scotiabank 05/13/22 TD Securities Savaria price target lowered to C$19 from C$22 at TD Securities

Recommendations	Peyto Exploration price target lowered to C$18.50 from C$19 at TD Securities » 11:59 08/12/22 08/12 11:59 08/12/22 11:59 PEYUF Peyto Exploration $10.61 / -0.19 (-1.76%) TD Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research PEYUF Peyto Exploration $10.61 / -0.19 (-1.76%) 08/11/22 National Bank Peyto Exploration price target lowered to C$19 from C$19.50 at National Bank 07/18/22 National Bank Peyto Exploration price target lowered to C$19.50 from C$23 at National Bank 07/14/22 Scotiabank Peyto Exploration price target raised to C$24 from C$23 at Scotiabank 06/30/22 Stifel Peyto Exploration price target lowered to C$19.25 from C$20 at Stifel
Recommendations	Killam Apartment REIT price target raised to C$22 from C$21 at TD Securities » 11:59 08/12/22 08/12 11:59 08/12/22 11:59 KMMPF Killam Apartment REIT $14.20 / +0.77 (+5.73%) TD Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research KMMPF Killam Apartment REIT $14.20 / +0.77 (+5.73%) 07/20/22 National Bank Killam Apartment price target lowered to C$19.25 from C$25 at National Bank 05/09/22 Raymond James Killam Apartment REIT price target lowered to C$24 from C$27 at Raymond James 05/09/22 Desjardins Killam Apartment REIT price target lowered to C$25 from C$26 at Desjardins 05/06/22 Canaccord Killam Apartment REIT price target lowered to C$23.50 from C$25.50 at Canaccord
Recommendations	Goeasy price target raised to C$200 from C$195 at TD Securities » 11:58 08/12/22 08/12 11:58 08/12/22 11:58 EHMEF Goeasy $110.36 / +8.68514 (+8.54%) TD Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research EHMEF Goeasy $110.36 / +8.68514 (+8.54%) 07/19/22 Goeasy appoints Jonathan Tetrault to board of directors 07/05/22 Goeasy announces $500M increase to securitization facility EHMEF Goeasy $110.36 / +8.68514 (+8.54%) 08/11/22 National Bank Goeasy price target raised to C$170 from C$155 at National Bank 08/04/22 TD Securities Goeasy price target lowered to C$195 from C$215 at TD Securities 07/20/22 Scotiabank Goeasy price target lowered to C$140 from C$160 at Scotiabank 07/08/22 Raymond James Goeasy price target lowered to C$202 from C$213 at Raymond James
Recommendations	Canadian Apartment Properties price target raised to C$60 at TD Securities » 11:58 08/12/22 08/12 11:58 08/12/22 11:58 CDPYF Canadian Apartment Properties $37.23 / -0.85 (-2.23%) TD Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research CDPYF Canadian Apartment Properties $37.23 / -0.85 (-2.23%) 06/30/22 Canadian Apartment Properties appoints Julian Schonfeldt as CIO 05/02/22 Canadian Apartment Properties purchases 172-site MHC in Alberta CDPYF Canadian Apartment Properties $37.23 / -0.85 (-2.23%) 07/20/22 National Bank CAP REIT price target lowered to C$50 from C$62.25 at National Bank 05/19/22 Desjardins Canadian Apartment Properties price target lowered to C$65 at Desjardins 05/19/22 Scotiabank Canadian Apartment Properties price target lowered to C$63 at Scotiabank 05/18/22 Raymond James Canadian Apartment Properties price target lowered to C$66 at Raymond James
Recommendations	Vermilion Energy price target raised to C$45 from C$40 at TD Securities » 11:57 08/12/22 08/12 11:57 08/12/22 11:57 VET Vermilion Energy $25.05 / -1.16 (-4.43%) TD Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events Options VET Vermilion Energy $25.05 / -1.16 (-4.43%) 08/11/22 Vermilion Energy raises quarterly dividend 33% to C$0.08 per share 04/26/22 Vermilion announces ISS, Glass Lewis recommend shareholders vote for resolutions 04/19/22 Vermilion Energy to issue $400M senior unsecured notes 03/28/22 Vermilion Energy raises FY22 production view to 86,000-88,000 boe/d VET Vermilion Energy $25.05 / -1.16 (-4.43%) 07/18/22 National Bank Vermilion Energy price target lowered to C$48 from C$52 at National Bank 07/14/22 Scotiabank Vermilion Energy price target raised to C$38 from C$36 at Scotiabank 06/30/22 Stifel Vermilion Energy upgraded to Buy from Hold at Stifel 06/27/22 Scotiabank Vermilion Energy upgraded to Outperform from Sector Perform at Scotiabank VET Vermilion Energy $25.05 / -1.16 (-4.43%) 03/07/22 Vermilion Energy reports Q4 diluted FFO $1.93 vs Q3 diluted FFO $1.59 VET Vermilion Energy $25.05 / -1.16 (-4.43%) 06/27/22 What You Missed On Wall Street On Monday 06/27/22 What You Missed On Wall Street This Morning 03/28/22 What You Missed On Wall Street On Monday 03/28/22 What You Missed On Wall Street This Morning 09:00 Today Vermilion Energy - VET VET Vermilion Energy $25.05 / -1.16 (-4.43%) 06/14/22 Vermilion Energy call volume above normal and directionally bullish 06/10/22 Vermilion Energy call volume above normal and directionally bullish 06/06/22 Vermilion Energy call volume above normal and directionally bullish 04/25/22 Vermilion Energy put volume heavy and directionally bearish

Events

Earnings calls, analyst events, roadshows and more

ADMP
Today at 13:00

Adamis Pharmaceuticals Corporation Firm Sponsored Meetings
SNDA
Today at 13:30

Sonida Senior Living - SNDA Conference Calls
BEEM
Today at 16:30

Beam Global - BEEM Conference Calls
VORB
Today at 16:30

Virgin Orbit - VORB Conference Calls
BOC
Tomorrow at 10:00

Boston Omaha Corporation Firm Sponsored Meetings

3701 S 10th St, Omaha, NE
ECL ...
2022-08-15 at 00:00

GII Bus Tour Conferences

Minneapolis, MN
AERI ...
2022-08-15 at 00:00

2022 Biotech Summer Summit Conferences

Newport, RI
2022-08-15 at 00:00

7th Annual Virtual Med Tech & Diagnostics 1:1 Conference Conferences

Virtual Conference
PZZA
2022-08-15 at 00:00

Papa John's Firm Sponsored Meetings

Virtual Meeting
CBIO
2022-08-15 at 00:00

Catalyst Biosciences, Inc. Firm Sponsored Meetings

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	AYTU X AYTU Aytu BioPharma Spot Secondary Managers: Cantor Fitzgerald & Canaccord Priced at: $0.43 21.5M Shares BRBR X BRBR BellRing Brands Spot Secondary Managers: JPMorgan, Barclays, Citi, Goldman Sachs & Morgan Stanley Priced at: $23.50 14.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MDNA X MDNA Medicenna Therapeutics Spot Secondary Managers: Guggenheim, Bloom Burton Securities Priced at: $1.50 13.333M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NUZE X NUZE NuZee Spot Secondary Managers: Maxim Priced at: $0.82 4.2M Shares PFLT X PFLT PennantPark Floating Rate Spot Secondary Managers: Morgan Stanley, Goldman Sachs, JPMorgan, Keefe Bruyette, RBC Capital & Truist Priced at: $12.40 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan, Jefferies Priced at: $215.00 3.49M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MIRM X MIRM Mirum Pharmaceuticals Spot Secondary Managers: JPMorgan, SVB Securities & Evercore ISI, Raymond James Priced at: $23.00 3.48M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TDW X TDW Tidewater Spot Secondary Managers: Morgan Stanley Priced at: $17.85 3.52M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	ATNX X ATNX Athenex Secondary Managers: SVB Securities Priced at: $.75 35.3M Shares CINC X CINC CinCor Pharma Secondary Managers: Goldman Sachs, Morgan Stanley, Jefferies & Piper Sandler Priced at: $30.00 7.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial EVTC X EVTC Evertec Secondary Managers: JPMorgan Priced at: $32.00 6.26M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LXU X LXU LSB Industries Secondary Managers: Goldman Sachs & UBS, Deutsche Bank, Jefferies, Piper Sandler, RBC Capital, BNP Paribas, Stifel Priced at: $13.00 13.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SOVO X SOVO Sovos Brands Secondary Managers: JPMorgan & Goldman Sachs, BofA, Credit Suisse, Barclays, UBS, Cowen, Piper Sandler, Stifel, William Blair, Telsey Advisory, Drexel Hamilton, Loop Capital Priced at: $14.00 8.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRNA X VRNA Verona Pharma Secondary Managers: Jefferies, Piper Sandler & Truist Priced at: $10.50 12.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial BNL X BNL Broadstone Net Lease Spot Secondary Managers: Goldman Sachs, BMO Capital, JPMorgan & Truist Priced at: $21.35 13M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KIDS X KIDS OrthoPediatrics Spot Secondary Managers: Piper Sandler & Stifel Priced at: $55.00 750K Shares MAIN X MAIN Main Street Spot Secondary Managers: RBC Capital, UBS & Wells Fargo Priced at: $42.85 1.17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	FRZA X FRZA Forza X1 IPO Managers: ThinkEquity Priced at: $5.00 3M Shares REBN X REBN Reborn Coffee IPO Managers: EF Hutton Priced at: $5.00 1.44M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial TGL X TGL Treasure Global IPO Managers: EF Hutton Priced at: $4.00 2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CERE X CERE Cerevel Therapeutics Secondary Managers: Morgan Stanley, Goldman Sachs, Jefferies & Evercore ISI, Loop Capital, Seibert Williams Priced at: $35.00 7.25M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INAB X INAB In8bio Secondary Managers: H.C. Wainwright Priced at: $1.90 5.39M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PTLO X PTLO Portillo's Secondary Managers: Jefferies & Morgan Stanley, BofA, Piper Sandler Priced at: $23.75 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CERT X CERT Certara Spot Secondary Managers: Morgan Stanley Priced at: $17.75 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INSP X INSP Inspire Medical Spot Secondary Managers: Goldman Sachs Priced at: $215.00 1M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

Mon	No deals
Tues	BIAF X BIAF Bioaffinity Technologies IPO Managers: WallachBeth $6.00-6.25 1.285M Shares
Wed	No deals
Thurs	RANI X RANI Rani Therapeutics Secondary Managers: BofA, Cantor Fitzgerald & UBS, BTIG, H.C. Wainwright $ Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	No deals

View All Syndicate Announcements »

CME Group price target lowered to $246 from $258 at UBS

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access